Back to Results
First PageMeta Content
Lymphocytic leukemia / Acute leukemia / Minimal residual disease / Acute lymphoblastic leukemia / Philadelphia chromosome / Hematopoietic stem cell transplantation / Childhood leukemia / The New England Journal of Medicine / Chromosome 21 / Medicine / Oncology / Leukemia


Microsoft Word - April 18 Final Briefing Document Minimal Residual Disease.doc
Add to Reading List

Open Document

File Size: 121,36 KB

Share Result on Facebook

City

Philadelphia / Berlin / Cairo / Frankfurt / /

Company

ALL (GMALL) Group / In Vitro Diagnostics / Northern Italy Leukaemia Group / Children’s Oncology Group / Polish Adult Leukemia Group / Hunger S.P. / Cancer- Childhood Leukemia Cooperative Group / /

Continent

North America / /

Currency

pence / /

Event

Man-Made Disaster / FDA Phase / /

Facility

White Oak Conference Center / /

Holiday

between day / /

IndustryTerm

Therapy of acute lymphoblastic leukemia / Treatment of Cancer / fusion product / fusion gene products / treatment of very highly resistant acute lymphoblastic leukemia / treatment of acute lymphoblastic leukemia / /

MedicalCondition

leukemia / tumor / Minimal Residual Disease / cancer / Residual Disease / disease / hematological malignancies / Acute Lymphoblastic Leukemia / childhood ALL / /

MedicalTreatment

cranial irradiation / chemotherapy / remission induction / /

Organization

U.S. Food and Drug Administration / American Society of Clinical Oncology / /

Person

Stephen Hunger / Gregory Reaman April / /

/

Product

prednisone / mitoxantrone / Interfant-99 / /

ProvinceOrState

Maryland / /

Region

Northern Italy / /

Technology

gene expression / chemotherapy / transplantation / /

SocialTag